Clinical Study of Sulfotanshinone Sodium Injection in Treating Non-Ischemic Retinal Vein OcclusionReportar como inadecuado




Clinical Study of Sulfotanshinone Sodium Injection in Treating Non-Ischemic Retinal Vein Occlusion - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Objectives: To study the effect of sulfotanshinone sodium SS injection in the treatment of non-ischemic retinal vein occlusion RVO. Methods: Sixty-two RVO patients treated in our hospital between Jan. 2013 and Oct. 2014 were randomly divided into Control Group 30 patients; Bendazol tablets and Treatment Group 32 patients, Bendazol tablets + SS injections, each with a follow-up period of 6 months. Statistical analysis was then performed on changes in visual acuity, central retinal thickness CRT and retinal circulation time RCT before and after the treatment. Results: After treatment, both Control Group and Treatment Group witnessed an improvement on visual acuity Control Group: t = 2.103, p = 0.044; Treatment Group: t = 8.021, p = 0.000. Visual acuity could be greatly improved in Treatment Group when compared with Control Group, with significant differences p < 0.01. Macular edema could be greatly relieved in Treatment Group measured by CRT t = 2.571, p = 0.007 while the difference was of no statistical significance in Control Group t = 1.016, p = 0.070. RCT were remarkably shortened in both groups Control Group: t = 43.83, p = 0.000; Treatment Group: t = 27.34, p = 0.000, and when compared with Control group, the changes in Treatment Group were more significant p < 0.05. Conclusion: SS injection could effectively improve the therapeutic effect in patients with non-ischemic retinal vein occlusion.

KEYWORDS

Sulfotanshinone Sodium Injection, Non-Ischemic Retinal Vein Occlusion

Cite this paper

Lu, B. and Wu, X. 2015 Clinical Study of Sulfotanshinone Sodium Injection in Treating Non-Ischemic Retinal Vein Occlusion. Chinese Medicine, 6, 83-89. doi: 10.4236-cm.2015.62009.





Autor: Bingwen Lu, Xingwei Wu*

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados